Pivotal roles of α-melanocyte-stimulating hormone and the melanocortin 4 receptor in leptin stimulation of prolactin secretion in rats

Journal of Neurochemistry

Volumn 85, Issue 2, 2003, Pages 338-347

  Watanobe, Hajime ^a   Schiöth, Helgi B ^b   Izumi, Junkichi ^c  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

^c ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Leptin; Melanocortin; Melanocortin receptor; Prolactin; melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; INTERMEDIN DERIVATIVE; LEPTIN; MELANOCORTIN 4 RECEPTOR; NEUTRALIZING ANTIBODY; PROLACTIN; PROLACTIN RELEASING FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FOOD DEPRIVATION; HORMONE BLOOD LEVEL; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM; TURNOVER TIME;

ANIMALIA;

EID: 0037388988     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01683.x     Document Type: Article

References (60)

1. Ahima R. S., Saper C. B., Flier J. S. and Elmquist J. K. (2000) Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 21, 263-307.
2. Arbogast L. A. and Voogt J. L. (1991) Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128, 997-1005.
3. Bagnol D., Lu X. Y., Kaelin C. B., Day H. E., Ollman M., Gantz I., Akil H., Barsh G. S. and Watson S. J. (1999) Anatomy of an endogenous antagonist: relationship between agouti-related protein and pro-opiomelanocortin in brain. J. Neurosci. 19, 1-7.
4. Baker R. A. and Herkenham M. (1995) Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J. Comp. Neurol. 358, 518-530.
5. Calapai G., Corica F., Corsonello A., Sautebin L., Di Rosa M., Campo G. M., Buemi M., Mauro V. N. and Caputi A. P. (1999) Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Invest. 104, 975-982.
6. Chen J. C. and Ramirez V. D. (1988) In vivo dopaminergic activity from nucleus accumbens, substantia nigra and ventral tegmental area in the freely moving rat: basal neurochemical output and prolactin effect. Neuroendocrinology 48, 329-335.
7. Chen J. C. and Ramirez V. D. (1989) Effects of prolactin on tyrosine hydroxylase activity of central dopaminergic neurons of male rats. Eur. J. Pharmacol. 166, 473-479.
8. Cowley M. A., Smart J. L., Rubinstein M., Cerdan M. G., Dano S., Horvath T. L., Cone R. D. and Low M. J. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484.
9. DeMaria J. E., Lerant A. A. and Freeman M. E. (1999) Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res. 837, 236-241.
10. Ellacott K. L. J., Lawrence C. B., Rothwell N. J. and Luckman S. M. (2002) PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 143, 368-374.
11. Ellerkmann E., Nagy G. M. and Frawley L. S. (1992) α-melanocytestimulating hormone is a mammotrophic factor released by neurointermediate lobe cells after estrogen treatment. Endocrinology 130, 133-138.
12. Fessler R. G., Deyo S. N., Meltzer H. Y. and Miller R. J. (1984) Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary. Brain Res. 299, 231-237.
13. Finn P. D., Cunningham M. J., Rickard D. G., Clifton D. K. and Steiner R. A. (2001) Serotonergic neurons are targets for leptin in the monkey. J. Clin. Endocrinol. Metab. 86, 422-426.
14. Flier J. S. (1998) What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83, 1407-1413.
15. Freeman M. E., Kanyicska B., Lerant A. and Nagy G. (2000) Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523-1631.
16. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F. J. and Burrell M. A. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. 280, E827-E847.
17. Gonzalez L. C., Pinilla L., Tena-Sempere M. and Aguilar E. (1999) Leptin (116-130) stimulates prolactin and luteinizing hormone secretion in fasted adult male rats. Neuroendocrinology 70, 213-220.
18. Harrold J. A., Widdowson P. S. and Williams G. (1999) Altered energy balance causes selective changes in melanocortin-4 (MC4-R.), but not melanocortin-3 (MC3-R.), receptors in specific hypothalamic regions. Diabetes 48, 267-271.
19. Hay-Schmidt A., Helboe L. and Larsen P. J. (2001) Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat. Neuroendocrinology 73, 215-226.
20. Henry B. A., Goding J. W., Alexander W. S., Tilbrook A. J., Canny B. J., Dunshea F., Rao A., Mansell A. and Clarke I. J. (1999) Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology 140, 1175-1182.
21. Hill J. B., Nagy G. M. and Frawley L. S. (1991) Suckling unmasks the stimulatory effect of dopamine on prolactin release: possible role for α-melanocyte-stimulating hormone as a mammotrope responsiveness factor. Endocrinology 129, 843-847.
22. Hill J. B., Lacy E. R., Nagy G. M., Görcs T. J. and Frawley L. S. (1993) Does α-melanocyte-stimulating hormone from the pars intermedia regulate suckling-induced prolactin release? Supportive evidence from morphological and functional studies. Endocrinology 133, 2991-2997.
23. Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoya M., Fukusumi S., Kitada C., Masuo Y., Asano T., Matsumoto H., Sekiguchi M., Kurokawa T., Nishimura O., Onda H. and Fujino M. (1998) A prolactin-releasing peptide in the brain. Nature 393, 272-276.
24. Hizume T., Watanobe H., Yoneda M., Suda T. and Schiöth H. B. (2000) Involvement of prolactin-releasing peptide in the prevulatory luteinizing hormone and prolactin surges in the rat. Biochem. Biophys. Res. Commun. 279, 35-39.
25. Izumi J., Inagaki M., Kiuchi Y., Matsumoto M., Yamazaki Y., Morioka D., Usami S. and Oguchi K. (1993) Sustained increase in adrenergic activity in gerbil striatum following transient ischemia. Jap. J. Pharmacol. 63, 143-149.
26. Jarry H., Heuer H., Schomburg L. and Bauer K. (2000) Prolactin-releasing peptides do not stimulate prolactin release in vivo. Neuroendocrinology 71, 262-267.
27. Jaworski R. P. and Janik J. (1997) Immunoneutralization of β-endorphin blocks prolactin release during suckling without affecting tubero-infudibular dopaminergic neural activity. Life Sci. 61, 1301-1311.
28. Jegou S., Boutelet I. and Vaudry H. (2000) Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurons of the rat arcuate nucleus. J. Neuroendocrinol. 12, 501-505.
29. Kistler-Heer V., Lauber M. E. and Lichtensteiger W. (1998) Different developmental patterns of melanocortin MC3 and MC4 receptor mRNA: predominance of MC4 in fetal rat nervous system. J. Neuroendocrinol. 10, 133-146.
30. Kohsaka A., Watanobe H., Kakizaki Y., Habu S. and Suda T. (1999) A significant role of leptin in the generation of steroid-induced luteinizing hormone and prolactin surges in female rats. Biochem. Biophys. Res. Commun. 254, 578-581.
31. 2+ concentration? J. Neuroendocrinol. 11, 171-179.
32. MacNeil D. J., Howard A. D., Guan X., Fong T. M., Nargund R. P., Bednarek M. A., Goulet M. T., Weinberg D. H., Strack A. M., Marsh D. J., Chen H. Y., Shen C. P., Chen A. S., Rosenblum C. I., MacNeil T., Tota M., MacIntyre E. D. and Van der Ploeg L. H. (2002) The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur. J. Pharmacol. 450, 93-109.
33. Mizuno T. M., Kleopoulos S. P., Bergen H. T., Roberts J. L., Priest C. A. and Mobbs C. V. (1998) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47, 294-297.
34. Moore R. Y. and Bloom F. E. (1978) Central catecholamine neuron system: anatomy and physiology of the dopamine systems. Ann. Rev. Neurosci. 1, 129-169.
35. Morgan W. W., Bartke A. and Pfeil K. (1981) Deficiency of dopamine in the median eminence of snell dwarf mice. Endocrinology 109, 2069-2075.
36. Mountjoy K. G., Mortrud M. T., Low M. J., Simerly R. B. and Cone R. D. (1994) Localization of the melanocortin-4 receptor (MC4-R.) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308.
37. Nagao T., Ibayashi S., Sadoshima S., Izumi J. and Fujishima M. (1995) Citalopram, a serotonin reuptake inhibitor, and brain ischemia in SHR. Brain Res. Bull. 38, 49-52.
38. 2+ entry. Am. J. Physiol. 274, E971-E977.
39. Orlando G., Brunetti L., Di Nisio C., Michelotto B., Recinella L., Ciabattoni G. and Vacca M. (2001) Effects of cocaine- and amphetamine-regulated transcript peptide, leptin, and orexins on hypothalamic serotonin release. Eur. J. Pharmacol. 430, 269-272.
40. Phelps C. J., Romero M. I. and Hurley D. L. (1995) Role of prolactin in developmental differentiation of hypophysiotropic tuberoinfundibular dopaminergic neurons. Rec. Prog. Horm. Res. 50, 471-481.
41. Renz M., Tomlinson E., Hultgren B., Levin N., Gu Q., Slumkets R. A., Lewin D. A. and Stewart T. A. (2000) Quantitative expression analysis of genes regulated by both obesity and leptin reveals a regulatory loop between leptin and pituitary-derived ACTH. J. Biol. Chem. 275, 10429-10436.
42. Roselli-Rehfuss L., Mountjoy K. G., Robbins L. S., Mortrud M. T., Low M. J., Tatro J. B., Entwistle M. L., Simerly R. B. and Cone R. D. (1993) Identification of a receptor for γ-melanotropic and other pro-opiomelanocortin peptides in the hypothalamus and the limbic system. Proc. Natl. Acad. Sci. USA 90, 8856-8860.
43. 2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage. Endocrinology 140, 4874-4885.
44. Samson W. K., Resch Z. T., Murphy T. C. and Chang J.-K. (1998) Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine 9, 289-291.
45. Sawchenko P. E. and Swanson L. H. (1983) The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J. Comp. Neurol. 218, 121-144.
46. Schiöth H. B. (2001) The physiological role of melanocortin receptors. Vit. Horm. 63, 195-232.
47. Schwartz M. W., Seeley R. J., Woods S. C., Weigle D. S., Campfield L. A., Burn P. and Baskin D. G. (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119-2123.
48. Shieh K. R. and Pan J. T. (1999) Stimulatory role of prolactin on the development of tuberoinfundibular dopaminergic neurons in prepubertal female rats: studies with cysteamine and somatostatin. J. Neuroendocrinol. 11, 907-917.
49. Tena-Sempere M., Pinilla L., González L. C., Diéguez C., Casanueva F. F. and Aguilar E. (1999) Leptin inhibits testosterone secretion from adult rat testis in vitro. J. Endocrinol. 161, 211-218.
50. Thornton J. E., Cheung C. C., Clifton D. K. and Steiner R. A. (1997) Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138, 5063-5066.
51. Tokita R., Nakata T., Katsumata H., Konishi S., Onodera H., Imaki J. and Minami S. (1999) Prolactin secretion in response to prolactin-releasing peptide and the expression of the prolactin-releasing peptide gene in the medulla oblongata are estrogen dependent in rats. Neurosci. Lett. 276, 103-106.
52. Turner J. D., Keith A. B., Smith A. I., McDermott J. R., Biggins J. A. and Edwardson J. A. (1983) Studies on the characterization of alpha-MSH-like immunoreactivity in rat hypothalamus. Regul. Pept. 5, 283-293.
53. Van de Kar L. D. and Bethea C. L. (1982) Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus. Neuroendocrinology 31, 225-230.
54. Verge D. and Calas A. (2000) Serotoninergic neurons and serotonin receptors: gains from cytochemical approaches. J. Chem. Neuroanat. 18, 41-56.
55. Watanobe H., Schiöth H. B., Wikberg J. E. S. and Suda T. (1999a) The melanocortin 4 receptor mediates leptin stimulation of luteinizing hormone and prolactin surges in steroid-primed ovariectomized rats. Biochem. Biophys. Res. Commun. 257, 860-864.
56. Watanobe H., Suda T., Wikberg J. E. S. and Schiöth H. B. (1999b) Evidence that physiological levels of circulating leptin exert a stimulatory effect on luteinizing hormone and prolactin surges in rats. Biochem. Biophys. Res. Commun. 263, 162-165.
57. Watanobe H., Schiöth H. B., Wikberg J. E. S. and Suda T. (2000a) Evaluation of the role for prolactin-releasing peptide in prolactin secretion induced by ether stress and suckling in the rat: comparison with vasoactive intestinal peptide. Brain Res. 865, 91-96.
58. Watanobe H., Schiöth H. B. and Suda T. (2000b) Stimulation of prolactin secretion by chronic, but not acute, administration of leptin in the rat. Brain Res. 887, 426-431.
59. Watanobe H., Yoneda M., Kakizaki Y., Kohsaka A., Suda T. and Schiöth H. B. (2001) Further evidence for a significant participation of the melanocortin 4 receptor in the preovulatory prolactin surge in the rat. Brain Res. Bull. 54, 521-525.
60. Yu W. H., Kimura M., Walczewska A., Karanth S. and McCann S. M. (1997) Role of leptin in hypothalamic-pituitary function. Proc. Natl Acad. Sci. USA 94, 1023-1028.